NP Life Sciences Health Industry Group Operating Income Growth & History (ACAT)

NP Life Sciences Health Industry Group's operating income was −$690 for fiscal 2023.

View full NP Life Sciences Health Industry Group company overview

NP Life Sciences Health Industry Group annual operating income history

NP Life Sciences Health Industry Group annual operating income

Fiscal yearPeriod endedOperating incomeChangeGrowth
20232023-12-31−$690$18,165
20222022-12-31−$18,855$46,826
20212021-12-31−$65,681$65,410
20202020-12-31−$131,091−$22,232
20192019-12-31−$108,859

NP Life Sciences Health Industry Group operating income trends

Between the periods ended 2019-12-31 and 2023-12-31, NP Life Sciences Health Industry Group's operating income increased from −$108,859 to −$690, a change of $108,169. The latest reported quarter, Q2 2025, shows −$21,683.

About the metric

What operating income means

Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.

Calculation and source

SEC-reported operating income

TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review NP Life Sciences Health Industry Group source filings ↗

Community posts

It’s quiet here.

No posts about ACAT yet. Start the conversation.

Write the first post